DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bumble Inc.
September 24, 2024 17:21 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Bumble To Contact Him Directly To Discuss Their Options ...
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
September 24, 2024 08:00 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
38/2024・Trifork Group AG – Financial Calendar 2025
September 23, 2024 09:30 ET
|
Trifork Group AG
Company announcement no. 38 / 2024 Schindellegi, Switzerland – 23 September 2024 Trifork Group – Financial Calendar 2025 Trifork today publishes its financial calendar for 2025. Q4 and Annual...
BIO-key Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control
September 23, 2024 08:28 ET
|
BIO-key International, Inc.
BIO-key, International (BKYI) Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control.
Kraig Biocraft Laboratories Launches Spider Silk Production at Recently Completed Higher Capacity Facility
September 23, 2024 07:05 ET
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB:KBLB) begins first BAM-1 parental strains production at its new production center with capacity to support 25 tons of spider silk
Sisäpiiritieto: Rush Factory Oyj on allekirjoittanut esisopimuksen yhdistymisestä Street Food Group Oyj:n kanssa
September 20, 2024 11:30 ET
|
Rush Factory Oyj
Rush Factory Oyj 20.09.2024 klo 18.29 Sisäpiiritieto: Rush Factory Oyj on allekirjoittanut esisopimuksen yhdistymisestä Street Food Group Oyj:n kanssa Rush...
ADR Ratio Change
September 19, 2024 16:30 ET
|
Biodexa Pharmaceuticals PLC
September 19, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical...
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PDD Holdings f/k/a Pinduoduo
September 19, 2024 11:49 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In PDD To Contact Him Directly To Discuss Their Options If you...
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix
September 19, 2024 11:38 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Orthofix To Contact Him Directly To Discuss Their Options If...
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Starbucks
September 19, 2024 11:32 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Starbucks To Contact Him Directly To Discuss Their Options If...